Portage Biotech (PRTG)
(Delayed Data from NSDQ)
$8.72 USD
-1.49 (-14.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.56 -0.16 (-1.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PRTG 8.72 -1.49(-14.59%)
Will PRTG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRTG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRTG
New Strong Buy Stocks for January 26th
Best Momentum Stocks to Buy for January 20th
PRTG: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for January 20th
How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160%
New Strong Buy Stocks for November 1st
Other News for PRTG
Wall Street Lower Ahead Of Interest Rate Move
US Stocks Mixed; General Mills Posts Upbeat Earnings
Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Portage Biotech Regains Nasdaq Compliance
Portage Biotech Reports Decreased Quarterly Loss